Related Experiment Video
Updated: May 26, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation
Merrin E Rutherford1, Rovina Ruslami, Winni Maharani
1Centre for International Health, University of Otago, Dunedin, New Zealand. merrin.rutherford@gmail.com.
Insights
Isoniazid preventive therapy (IPT) adherence is very low in Indonesian children under five, with cost and access being major barriers. Addressing these issues is crucial for reducing childhood tuberculosis.
Area of Science:
- Public Health
- Pediatric Infectious Diseases
- Tuberculosis Control
Background:
- Isoniazid preventive therapy (IPT) is recommended for child contacts of infectious tuberculosis cases.
- Low reported adherence to IPT in children is a significant public health concern.
- Risk factors for poor IPT adherence in pediatric populations remain largely uncharacterized.
Purpose of the Study:
- To determine IPT adherence rates in children under five years old in an Indonesian lung clinic.
- To identify risk factors associated with poor IPT adherence in this pediatric cohort.
- To explore caregiver-reported barriers to IPT adherence through qualitative methods.
Main Methods:
- Prospective study of children under five receiving IPT.
- Logistic regression analysis to identify risk factors for adherence (defined as ≤3 months prescription collection).
- In-depth interviews with caregivers of children with both good and poor adherence.
Main Results:
- 74.4% of 82 eligible children exhibited poor IPT adherence.
- High transport costs (OR 3.3) and medication costs (OR 20.0) were significantly associated with poor adherence.
- Qualitative analysis revealed access, medication issues, health service experiences, and caregiver knowledge as key determinants.
Conclusions:
- Childhood IPT adherence in this Indonesian setting is extremely low.
- Financial, knowledge, health service, and medication-related barriers contribute to poor adherence.
- Evidence-based interventions targeting these barriers are essential for effective childhood tuberculosis reduction.
Background:
It is recommended that young child contacts of sputum smear positive tuberculosis cases receive isoniazid preventive therapy (IPT) but reported adherence is low and risk factors for poor adherence in children are largely unknown.
Methods:
We prospectively determined rates of IPT adherence in children < 5 yrs in an Indonesian lung clinic. Possible risk factors for poor adherence, defined as ≤3 months prescription collection, were calculated using logistic regression. To further investigate adherence barriers in-depth interviews were conducted with caregivers of children with good and poor adherence.
Results:
Eighty-two children eligible for IPT were included, 61 (74.4%) of which had poor adherence. High transport costs (OR 3.3, 95% CI 1.1-10.2) and medication costs (OR 20.0, 95% CI 2.7-414.5) were significantly associated with poor adherence in univariate analysis. Access, medication barriers, disease and health service experience and caregiver TB and IPT knowledge and beliefs were found to be important determinants of adherence in qualitative analysis.
Conclusion:
Adherence to IPT in this setting in Indonesia is extremely low and may result from a combination of financial, knowledge, health service and medication related barriers. Successful reduction of childhood TB urgently requires evidence-based interventions that address poor adherence to IPT.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
